TransMedics Long Term Debt Total vs Net Receivables Analysis

TMDX Stock

USD 64.26 1.45 2.21%

TransMedics financial indicator trend analysis is much more than just breaking down TransMedics Group prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether TransMedics Group is a good investment. Please check the relationship between TransMedics Long Term Debt Total and its Net Receivables accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransMedics Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Long Term Debt Total vs Net Receivables

Long Term Debt Total vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of TransMedics Group Long Term Debt Total account and Net Receivables. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between TransMedics' Long Term Debt Total and Net Receivables is 0.59. Overlapping area represents the amount of variation of Long Term Debt Total that can explain the historical movement of Net Receivables in the same time period over historical financial statements of TransMedics Group, assuming nothing else is changed. The correlation between historical values of TransMedics' Long Term Debt Total and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt Total of TransMedics Group are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Long Term Debt Total i.e., TransMedics' Long Term Debt Total and Net Receivables go up and down completely randomly.

Correlation Coefficient

0.59

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Long Term Debt Total

Net Receivables

Most indicators from TransMedics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into TransMedics Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransMedics Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

At this time, TransMedics' Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.96 in 2024, despite the fact that Tax Provision is likely to grow to (1.4 M).

	2021	2022	2023	2024 (projected)
Total Operating Expenses	60.6M	96.7M	182.8M	192.0M
Research Development	22.3M	26.8M	36.1M	22.2M

Total Operating Expenses Research Development

TransMedics fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Short Term Investments	Inventory	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Other Current Liab	Net Receivables	Common Stock Shares Outstanding	Other Stockholder Equity	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total	Non Currrent Assets Other
Total Assets		0.98	0.7	-0.09	0.81	-0.75	0.86	0.99	-0.12	0.98	-0.37	0.99	0.94	1.0	0.61	0.91	0.96	0.99	0.72	-0.09	0.98	0.98	0.96	0.64	0.98	-0.09
Total Current Liabilities	0.98		0.7	-0.16	0.8	-0.8	0.92	0.96	-0.06	0.97	-0.37	0.99	0.95	0.98	0.64	0.93	0.98	0.98	0.73	-0.04	0.97	0.97	0.94	0.65	0.97	-0.03
Total Stockholder Equity	0.7	0.7		-0.12	0.93	-0.74	0.47	0.69	0.06	0.59	-0.08	0.73	0.53	0.73	0.96	0.83	0.82	0.7	0.87	-0.24	0.6	0.58	0.52	0.16	0.58	0.01
Other Liab	-0.09	-0.16	-0.12		0.0	0.12	-0.36	-0.08	-0.44	-0.17	0.17	-0.14	-0.2	-0.07	-0.09	0.01	-0.15	-0.11	0.24	0.35	-0.16	-0.13	-0.14	-0.34	-0.14	-0.35
Net Tangible Assets	0.81	0.8	0.93	0.0		-0.75	0.58	0.79	-0.27	0.71	-0.05	0.82	0.66	0.85	0.86	0.89	0.87	0.81	0.84	-0.2	0.72	0.71	0.65	0.27	0.71	-0.3
Retained Earnings	-0.75	-0.8	-0.74	0.12	-0.75		-0.69	-0.72	0.01	-0.66	0.01	-0.81	-0.66	-0.78	-0.79	-0.82	-0.82	-0.73	-0.79	0.01	-0.66	-0.65	-0.6	-0.27	-0.65	0.02
Accounts Payable	0.86	0.92	0.47	-0.36	0.58	-0.69		0.82	-0.02	0.9	-0.32	0.88	0.87	0.84	0.44	0.75	0.84	0.85	0.48	-0.15	0.9	0.89	0.88	0.75	0.89	0.02
Cash	0.99	0.96	0.69	-0.08	0.79	-0.72	0.82		-0.08	0.96	-0.5	0.98	0.93	0.98	0.59	0.93	0.94	1.0	0.71	-0.07	0.96	0.96	0.94	0.56	0.96	-0.04
Other Assets	-0.12	-0.06	0.06	-0.44	-0.27	0.01	-0.02	-0.08		-0.05	-0.31	-0.06	-0.07	-0.14	0.1	-0.1	-0.02	-0.08	0.0	-0.04	-0.05	-0.08	-0.04	0.06	-0.07	0.98
Long Term Debt	0.98	0.97	0.59	-0.17	0.71	-0.66	0.9	0.96	-0.05		-0.42	0.97	0.97	0.96	0.49	0.83	0.92	0.97	0.62	-0.07	1.0	1.0	1.0	0.77	1.0	-0.01
Short Term Investments	-0.37	-0.37	-0.08	0.17	-0.05	0.01	-0.32	-0.5	-0.31	-0.42		-0.36	-0.46	-0.34	0.02	-0.39	-0.32	-0.45	-0.12	-0.16	-0.42	-0.44	-0.44	-0.14	-0.44	-0.43
Inventory	0.99	0.99	0.73	-0.14	0.82	-0.81	0.88	0.98	-0.06	0.97	-0.36		0.95	0.99	0.66	0.93	0.98	0.98	0.75	-0.05	0.97	0.97	0.94	0.62	0.97	-0.03
Total Liab	0.94	0.95	0.53	-0.2	0.66	-0.66	0.87	0.93	-0.07	0.97	-0.46	0.95		0.92	0.45	0.81	0.91	0.94	0.59	0.12	0.97	0.97	0.97	0.74	0.97	-0.03
Total Current Assets	1.0	0.98	0.73	-0.07	0.85	-0.78	0.84	0.98	-0.14	0.96	-0.34	0.99	0.92		0.65	0.93	0.96	0.99	0.75	-0.1	0.96	0.96	0.93	0.59	0.96	-0.12
Common Stock	0.61	0.64	0.96	-0.09	0.86	-0.79	0.44	0.59	0.1	0.49	0.02	0.66	0.45	0.65		0.77	0.76	0.6	0.9	-0.18	0.5	0.48	0.42	0.08	0.48	0.05
Property Plant Equipment	0.91	0.93	0.83	0.01	0.89	-0.82	0.75	0.93	-0.1	0.83	-0.39	0.93	0.81	0.93	0.77		0.95	0.92	0.87	0.01	0.84	0.85	0.79	0.33	0.84	-0.06
Other Current Liab	0.96	0.98	0.82	-0.15	0.87	-0.82	0.84	0.94	-0.02	0.92	-0.32	0.98	0.91	0.96	0.76	0.95		0.95	0.83	0.0	0.93	0.92	0.89	0.57	0.92	0.0
Net Receivables	0.99	0.98	0.7	-0.11	0.81	-0.73	0.85	1.0	-0.08	0.97	-0.45	0.98	0.94	0.99	0.6	0.92	0.95		0.71	-0.1	0.98	0.98	0.95	0.61	0.97	-0.05
Common Stock Shares Outstanding	0.72	0.73	0.87	0.24	0.84	-0.79	0.48	0.71	0.0	0.62	-0.12	0.75	0.59	0.75	0.9	0.87	0.83	0.71		0.09	0.63	0.62	0.57	0.15	0.62	0.02
Other Stockholder Equity	-0.09	-0.04	-0.24	0.35	-0.2	0.01	-0.15	-0.07	-0.04	-0.07	-0.16	-0.05	0.12	-0.1	-0.18	0.01	0.0	-0.1	0.09		-0.07	-0.05	-0.04	-0.09	-0.05	0.05
Short Long Term Debt Total	0.98	0.97	0.6	-0.16	0.72	-0.66	0.9	0.96	-0.05	1.0	-0.42	0.97	0.97	0.96	0.5	0.84	0.93	0.98	0.63	-0.07		1.0	0.99	0.76	1.0	-0.01
Property Plant And Equipment Net	0.98	0.97	0.58	-0.13	0.71	-0.65	0.89	0.96	-0.08	1.0	-0.44	0.97	0.97	0.96	0.48	0.85	0.92	0.98	0.62	-0.05	1.0		0.99	0.75	1.0	-0.03
Current Deferred Revenue	0.96	0.94	0.52	-0.14	0.65	-0.6	0.88	0.94	-0.04	1.0	-0.44	0.94	0.97	0.93	0.42	0.79	0.89	0.95	0.57	-0.04	0.99	0.99		0.8	1.0	0.01
Net Debt	0.64	0.65	0.16	-0.34	0.27	-0.27	0.75	0.56	0.06	0.77	-0.14	0.62	0.74	0.59	0.08	0.33	0.57	0.61	0.15	-0.09	0.76	0.75	0.8		0.76	0.06
Non Current Assets Total	0.98	0.97	0.58	-0.14	0.71	-0.65	0.89	0.96	-0.07	1.0	-0.44	0.97	0.97	0.96	0.48	0.84	0.92	0.97	0.62	-0.05	1.0	1.0	1.0	0.76		-0.02
Non Currrent Assets Other	-0.09	-0.03	0.01	-0.35	-0.3	0.02	0.02	-0.04	0.98	-0.01	-0.43	-0.03	-0.03	-0.12	0.05	-0.06	0.0	-0.05	0.02	0.05	-0.01	-0.03	0.01	0.06	-0.02

Click cells to compare fundamentals

TransMedics Account Relationship Matchups

TransMedics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	105.3M	152.0M	134.9M	277.1M	706.0M	741.3M
Total Current Liabilities	16.1M	11.9M	23.2M	23.7M	54.9M	57.7M
Total Stockholder Equity	54.6M	103.9M	67.9M	187.4M	137.2M	144.1M
Other Liab	1.1M	759K	389K	1.6M	1.4M	901.6K
Net Tangible Assets	54.6M	103.9M	67.9M	187.4M	215.5M	226.3M
Retained Earnings	(369.5M)	(398.2M)	(442.4M)	(478.7M)	(503.7M)	(528.9M)
Accounts Payable	7.2M	1.2M	6.7M	3.3M	12.7M	13.4M
Cash	20.1M	24.6M	25.6M	201.2M	394.8M	414.6M
Long Term Debt	34.1M	34.7M	35.2M	58.7M	506.2M	531.5M
Inventory	11.2M	11.9M	14.9M	20.6M	44.2M	46.4M
Total Liab	50.7M	48.1M	67.0M	89.8M	568.8M	597.3M
Total Current Assets	100.0M	146.8M	118.7M	252.3M	510.7M	536.2M
Common Stock	424.1M	502.2M	510.5M	666.3M	641.1M	375.9M
Property Plant Equipment	4.8M	4.8M	15.7M	24.4M	28.0M	29.4M
Other Current Liab	8.7M	10.4M	16.3M	17.2M	36.2M	38.0M
Net Receivables	6.6M	6.9M	5.9M	27.6M	63.6M	66.8M
Common Stock Shares Outstanding	14.2M	24.7M	27.6M	29.6M	32.5M	24.3M
Other Stockholder Equity	(105.3M)	(95K)	68.0M	(225K)	(202.5K)	(192.4K)
Short Long Term Debt Total	34.1M	34.7M	43.8M	67.6M	515.9M	541.7M
Property Plant And Equipment Net	4.8M	4.8M	15.7M	24.4M	180.5M	189.5M
Current Deferred Revenue	166K	263K	250K	241K	2.0M	2.1M
Net Debt	14.1M	10.1M	(17.0M)	(133.6M)	121.1M	127.2M
Non Current Assets Total	5.3M	5.3M	16.2M	24.9M	195.4M	205.2M
Cash And Short Term Investments	80.7M	125.6M	92.5M	201.2M	394.8M	414.6M
Common Stock Total Equity	331.2M	424.1M	502.2M	510.5M	587.1M	389.0M
Long Term Debt Total	33.7M	34.1M	34.7M	35.2M	40.5M	31.8M
Liabilities And Stockholders Equity	105.3M	152.0M	134.9M	277.1M	706.0M	741.3M
Non Current Liabilities Total	34.5M	36.3M	43.8M	66.1M	513.9M	539.6M
Other Current Assets	1.5M	4.7M	5.5M	2.9M	8.0M	8.4M
Net Invested Capital	88.8M	138.5M	103.1M	246.1M	643.4M	675.6M
Property Plant And Equipment Gross	4.8M	4.8M	15.7M	24.4M	201.8M	211.9M
Accumulated Other Comprehensive Income	(2K)	(95K)	(188K)	(225K)	(199K)	(209.0K)
Net Working Capital	83.9M	134.9M	95.5M	228.6M	455.7M	478.5M
Capital Stock	424.1M	502.2M	510.5M	666.3M	641.1M	563.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

TransMedics Long Term Debt Total vs Net Receivables Analysis

Long Term Debt Total vs Net Receivables

Long Term Debt Total vs Net Receivables Correlation Analysis

Correlation Coefficient

Long Term Debt Total

Net Receivables

TransMedics fundamental ratios Correlations

TransMedics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

TransMedics fundamental ratios Accounts

Also Currently Popular

Additional Tools for TransMedics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Net Receivables	+ 1.0	Cash
Short Long Term Debt Total	+ 1.0	Long Term Debt
Property Plant And Equipment Net	+ 1.0	Long Term Debt
Current Deferred Revenue	+ 1.0	Long Term Debt
Non Current Assets Total	+ 1.0	Long Term Debt

Other Current Liab	- 0.82	Retained Earnings
Property Plant Equipment	- 0.82	Retained Earnings
Inventory	- 0.81	Retained Earnings
Retained Earnings	- 0.8	Total Current Liabilities
Common Stock Shares Outstanding	- 0.79	Retained Earnings
Common Stock	- 0.79	Retained Earnings